Ai-based Small Molecule Therapeutics Pioneer Athos Therapeutics Selects Vultr For Secure Ai Training In The Cloud

Athos is a pioneer in using artificial intelligence and machine learning to develop precision small-molecule therapeutics for immune-mediated diseases and cancer. They have partnered with top hospitals and universities to analyze patient data and have chosen Vultr as their cloud infrastructure provider for reliable and secure access to NVIDIA GPUs.